PS
MEDP icon

Portfolio Strategies’s Medpace MEDP Stock Holding History

Portfolio Strategies’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-867
Closed -$350K – 90
2024
Q1 		$350K Buy
+867
New +$305K 0.02% 103

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Portfolio Strategies's MEDP Position: Q2 2024 in Review

Portfolio Strategies sold out of Medpace (MEDP) in Q2 2024, closing a stake of 867 shares — an estimated $350K sold.

Portfolio Strategies first reported a position in MEDP in Q1 2024 and held it in 1 quarter. The position peaked at $350K in Q1 2024. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

  • Portfolio Strategies reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
  • Portfolio Strategies sold 867 Medpace shares in Q2 2024, an estimated $350K.
  • Portfolio Strategies first reported a position in Medpace in Q1 2024 and held it in 1 quarter.
  • Portfolio Strategies's Medpace position peaked at $350K in Q1 2024.
  • 623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Portfolio Strategies's 13F filing for Q2 2024, filed 12 Aug 2024.